Rick Blum is meticulous about planning, ordering, and taking the medication he is prescribed to slow the progression of ...

Roche Holdings AG (OTC:RHHBY) on Tuesday released statistically significant final overall survival (OS) results from the ...

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive ...

Integrating a blood-based biomarker assay into clinical workflows can enhance decision-making in patients with multiple ...

Discover a study that compared two treatment methods for overactive bladder in patients with multiple sclerosis. Learn more.

The results of the MIROCALS randomized clinical trial have shown that adding low-dose interleukin-2 (IL2LD) to standard ...